Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance

S Bagchi, R Yuan, EG Engleman - Annual Review of Pathology …, 2021 - annualreviews.org
Immune checkpoint inhibitors (ICIs) have made an indelible mark in the field of cancer
immunotherapy. Starting with the approval of anti-cytotoxic T lymphocyte-associated protein …
被引用次数：1362 相关文章

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

S Bagchi, R Yuan, EG Engleman - Annual Review of Pathology …, 2021 - cir.nii.ac.jp
抄録< jats: p> Immune checkpoint inhibitors (ICIs) have made an indelible mark in the field of
cancer immunotherapy. Starting with the approval of anti-cytotoxic T lymphocyte-associated …

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.

S Bagchi, R Yuan, EG Engleman - Annual Review of Pathology, 2020 - europepmc.org
Immune checkpoint inhibitors (ICIs) have made an indelible mark in the field of cancer
immunotherapy. Starting with the approval of anti-cytotoxic T lymphocyte-associated protein …

Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

S Bagchi, R Yuan… - Annual review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) have made an indelible mark in the field of cancer
immunotherapy. Starting with the approval of anti-cytotoxic T lymphocyte-associated protein …